Literature DB >> 20971849

A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.

John S Albin1, Rebecca S LaRue, Jessalyn A Weaver, William L Brown, Keisuke Shindo, Elena Harjes, Hiroshi Matsuo, Reuben S Harris.   

Abstract

Human APOBEC3F (huA3F) potently restricts the infectivity of HIV-1 in the absence of the viral accessory protein virion infectivity factor (Vif). Vif functions to preserve viral infectivity by triggering the degradation of huA3F but not rhesus macaque A3F (rhA3F). Here, we use a combination of deletions, chimeras, and systematic mutagenesis between huA3F and rhA3F to identify Glu(324) as a critical determinant of huA3F susceptibility to HIV-1 Vif-mediated degradation. A structural model of the C-terminal deaminase domain of huA3F indicates that Glu(324) is a surface residue within the α4 helix adjacent to residues corresponding to other known Vif susceptibility determinants in APOBEC3G and APOBEC3H. This structural clustering suggests that Vif may bind a conserved surface present in multiple APOBEC3 proteins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971849      PMCID: PMC3003379          DOI: 10.1074/jbc.M110.173161

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

2.  Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.

Authors:  Kara G Lassen; Silke Wissing; Michael A Lobritz; Mario Santiago; Warner C Greene
Journal:  J Biol Chem       Date:  2010-07-12       Impact factor: 5.157

3.  Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.

Authors:  John S Albin; Guylaine Haché; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.

Authors:  Shivender M D Shandilya; Madhavi N L Nalam; Ellen A Nalivaika; Phillip J Gross; Johnathan C Valesano; Keisuke Shindo; Ming Li; Mary Munson; William E Royer; Elena Harjes; Takahide Kono; Hiroshi Matsuo; Reuben S Harris; Mohan Somasundaran; Celia A Schiffer
Journal:  Structure       Date:  2010-01-13       Impact factor: 5.006

5.  Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.

Authors:  Rebecca S Larue; Joy Lengyel; Stefán R Jónsson; Valgerdur Andrésdóttir; Reuben S Harris
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

Authors:  Bärbel Schröfelbauer; Darlene Chen; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

7.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

8.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

9.  Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.

Authors:  Roberto Mariani; Darlene Chen; Bärbel Schröfelbauer; Francisco Navarro; Renate König; Brooke Bollman; Carsten Münk; Henrietta Nymark-McMahon; Nathaniel R Landau
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

10.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

View more
  40 in total

1.  Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.

Authors:  Judd F Hultquist; Joy A Lengyel; Eric W Refsland; Rebecca S LaRue; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

Review 3.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

4.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

5.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Authors:  Rebecca M McDougle; Judd F Hultquist; Alex C Stabell; Sara L Sawyer; Reuben S Harris
Journal:  Virology       Date:  2013-03-29       Impact factor: 3.616

Review 6.  Structural insights for HIV-1 therapeutic strategies targeting Vif.

Authors:  Jason D Salter; Guillermo A Morales; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2014-08-12       Impact factor: 13.807

7.  Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Authors:  John S Albin; William L Brown; Reuben S Harris
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

8.  APOBEC3F determinants of HIV-1 Vif sensitivity.

Authors:  Allison M Land; Nadine M Shaban; Leah Evans; Judd F Hultquist; John S Albin; Reuben S Harris
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

9.  Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.

Authors:  Tayyba T Baig; Yuqing Feng; Linda Chelico
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

10.  Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

Authors:  John S Albin; John S Anderson; Jeffrey R Johnson; Elena Harjes; Hiroshi Matsuo; Nevan J Krogan; Reuben S Harris
Journal:  J Mol Biol       Date:  2013-01-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.